Acurx Pharmaceuticals (ACXP) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.37
-0.3
-0.22
-0.15

Details

Expected EPS
-0.145
Actual EPS
-0.17
Surprise EPS
-0.03
Surprise Percent
+17.24%

Description

Acurx Pharmaceuticals (ACXP) has reported earnings of -0.17 per share for Q4 2024.

0 Comments

Share your thoughts